Rapid use of real-world data in safety signal assessment

被引:0
|
作者
McDermott, Rachel [1 ]
Patadia, Vaishali [2 ]
von Klot, Stephanie [3 ]
Asubonteng, Julius [4 ]
Miller, Mary K. [5 ]
Golchin, Negar [6 ]
Manlik, Katrin [7 ]
机构
[1] Shionogi BV, Amsterdam, Netherlands
[2] Amgen Inc, Thousand Oaks, CA USA
[3] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[4] Regeneron Pharmaceut, Tarrytown, NY USA
[5] Genentech Roche, San Francisco, CA USA
[6] Bristol Myers Squibb BMS, New York, NY USA
[7] Bayer AG, Leverkusen, Germany
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
1056
引用
收藏
页码:496 / 497
页数:2
相关论文
共 50 条
  • [21] Therapy for AMD: real-world data on the safety of brolucizumab
    Bitzer, Michaela
    AUGENHEILKUNDE UP2DATE, 2023, 13 (01) : 5 - 6
  • [22] Real-world study: from real-world data to real-world evidence
    Wen, Yi
    TRANSLATIONAL BREAST CANCER RESEARCH, 2020, 1
  • [23] The Use of Real-World Data to Assess the Impact of Safety-Related Regulatory Interventions
    Dal Pan, Gerald J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 98 - 107
  • [24] Conundrum of Using Real-World Observational Data to Inform Real-World Conclusions About Safety and Efficacy
    Gibson, C. Michael
    Nafee, Tarek
    Kerneis, Mathieu
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (15) : 1801 - 1803
  • [25] The Use of Real-world Data to Generate Real-world Evidence to Accelerate Neonatal Drug Development
    Jackson, Shawn S.
    Cravero, Joseph P.
    Sun, Lena
    Davis, Jonathan M.
    JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY, 2025, 37 (01) : 110 - 113
  • [26] Translating real-world evidence/real-world data
    Ravenstijn, Paulien
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (05):
  • [27] Safety assessment of esomeprazole: real-world adverse event signal mining and analysis based on FAERS database
    Wang, Bojing
    Huang, Shu
    Li, Shiqi
    Deng, Yaqi
    Li, Ziyan
    Wang, Yizhou
    Shi, Xiaomin
    Zhang, Wei
    Shi, Lei
    Tang, Xiaowei
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [28] ASSESSMENT OF REAL-WORLD DATA SOURCES AND A HYBRID APPROACH IN REAL-WORLD EVIDENCE GENERATION USING UNHARMONIZED DATA SOURCES
    Toh, K. C.
    Goh, C. H.
    Goh, V
    Dong, Z.
    Dumpala, L. S.
    Maity, S.
    Wu, J. Y.
    Kleinman, N.
    Lee, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S407 - S407
  • [29] Real-world data for efficient health technology assessment
    Hall, Peter S.
    EUROPEAN JOURNAL OF CANCER, 2017, 79 : 235 - 237
  • [30] Real-world assessment of sparsentan's drug safety framework
    Fu, Wenjing
    Wang, Jingyu
    Xue, Yuzhou
    Pan, Dikang
    RENAL FAILURE, 2025, 47 (01)